Modulight Corporation | Company Release | November 18, 2026 at 16:00:00 EET
During the year 2027, Modulight will publish its financial information as follows:
- Financial Statement Bulletin for 2026 (1–12/2026): March 16, 2027
- 1Q27 Interim Report (1–3/2027): April 23, 2027
- 1H27 Half-year Financial Report (1–6/2027): August 20, 2027
- 3Q27 Interim Report (1–9/2027): October 29, 2027
Report by the Board of Directors and Financial Statements 2026The Report by the Board of Directors and the Financial Statements for the financial year 2026 will be published on the company's website at https://modulight.com/reports-presentations/ on March 19, 2027.
Annual General Meeting 2027The Annual General Meeting is scheduled to be held on May 3, 2027. The meeting will be convened later by the Board of Directors of Modulight Corporation.
Contacts
CEO Seppo Orsila m. +358 40 830 4671CFO Anca Guina m. +358 40 830 4674IR Ulla Haapanen m. +358 40 830 4676Email: ir@modulight.com
Modulight in brief
Modulight Corporation is a life science company that designs and manufactures laser devices for the treatment of cancer and eye diseases. The company also manufactures products for other high value-add applications including flow cytometry, microscopy, semiconductor, quantum, and defense. The company’s products include medical devices, subsystems, software, cloud services, and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.
Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #KillCancer